These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 24942811)

  • 1. Clinical application of growth factors and cytokines in wound healing.
    Barrientos S; Brem H; Stojadinovic O; Tomic-Canic M
    Wound Repair Regen; 2014; 22(5):569-78. PubMed ID: 24942811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging new drugs for wound repair.
    Meier K; Nanney LB
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):23-37. PubMed ID: 16503824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response.
    Robson MC; Hill DP; Smith PD; Wang X; Meyer-Siegler K; Ko F; VandeBerg JS; Payne WG; Ochs D; Robson LE
    Ann Surg; 2000 Apr; 231(4):600-11. PubMed ID: 10749622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review.
    Zubair M; Ahmad J
    Rev Endocr Metab Disord; 2019 Jun; 20(2):207-217. PubMed ID: 30937614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
    Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
    Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects.
    Shao M; Hussain Z; Thu HE; Khan S; de Matas M; Silkstone V; Qin HL; Bukhari SNA
    Crit Rev Ther Drug Carrier Syst; 2017; 34(5):387-452. PubMed ID: 29256838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome study of growth factor-treated pressure ulcers.
    Payne WG; Ochs DE; Meltzer DD; Hill DP; Mannari RJ; Robson LE; Robson MC
    Am J Surg; 2001 Jan; 181(1):81-6. PubMed ID: 11248182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation.
    Iwamoto S; Lin X; Ramirez R; Carson P; Fiore D; Goodrich J; Yufit T; Falanga V
    Int J Low Extrem Wounds; 2013 Dec; 12(4):256-64. PubMed ID: 24275756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pilot studies reveal the potential of a vitronectin: growth factor complex as a treatment for chronic wounds.
    Upton Z; Wallace HJ; Shooter GK; van Lonkhuyzen DR; Yeoh-Ellerton S; Rayment EA; Fleming JM; Broszczak D; Queen D; Sibbald RG; Leavesley DI; Stacey MC
    Int Wound J; 2011 Oct; 8(5):522-32. PubMed ID: 21914133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factors for treating diabetic foot ulcers.
    Martí-Carvajal AJ; Gluud C; Nicola S; Simancas-Racines D; Reveiz L; Oliva P; Cedeño-Taborda J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008548. PubMed ID: 26509249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors in the treatment of diabetic foot ulcers: new technologies, any promises?
    Papanas N; Maltezos E
    Int J Low Extrem Wounds; 2007 Mar; 6(1):37-53. PubMed ID: 17344201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors in the treatment of diabetic foot ulcers.
    Bennett SP; Griffiths GD; Schor AM; Leese GP; Schor SL
    Br J Surg; 2003 Feb; 90(2):133-46. PubMed ID: 12555288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.
    Pierce GF; Tarpley JE; Allman RM; Goode PS; Serdar CM; Morris B; Mustoe TA; Vande Berg J
    Am J Pathol; 1994 Dec; 145(6):1399-410. PubMed ID: 7992843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dressings and topical agents containing hyaluronic acid for chronic wound healing.
    Roehrs H; Stocco JG; Pott F; Blanc G; Meier MJ; Dias FA
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD012215. PubMed ID: 37497805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New developments in the treatment of diabetic foot ulcers].
    Bakker K; Schaper NC
    Ned Tijdschr Geneeskd; 2000 Feb; 144(9):409-12. PubMed ID: 10719543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of chronic pressure ulcers: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(3):1-203. PubMed ID: 23074533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cell cycle for wound stratification in clinical trials: analysis of a pressure ulcer clinical trial utilizing cyclin D/cdk4.
    Vande Berg JS; Rose MA; Payne WG; Haywood-Reid PL; Robson MC
    Wound Repair Regen; 2003; 11(1):11-8. PubMed ID: 12581422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with novel HYBENX® root canal cleanser suggests biofilms blocked healing of human wounds: case series.
    Gitterle M
    J Biol Regul Homeost Agents; 2020; 34(1 Suppl. 1):1-11. DENTAL SUPPLEMENT. PubMed ID: 32064830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers.
    Jaschke E; Zabernigg A; Gattringer C
    Int J Dermatol; 1999 May; 38(5):380-6. PubMed ID: 10369552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.